Carlos Zaragoza Sánchez,Mónica Gómez Parrizas,Begoña Lavín Plaza,Carlos Tarín Cerezo
申请号：
US14110805
公开号：
US09644019B2
申请日:
2011.12.01
申请国别(地区):
US
年份:
2017
代理人:
摘要：
The present invention relates to the use of an Extracellular Matrix Metalloproteinase Inducer (EMMPRIN) inhibitor for preventing and/or treating cardiac damage arising after an ischemic process followed by reperfusion. The authors of the present invention have observed that EMMPRIN expression increases in subjects who have suffered ischemia/reperfusion, ascertaining that an EMMPRIN inhibitor is capable of reducing the cardiac damage caused after ischemia followed by reperfusion, both in vitro and in vivo.
